Cited 4 times in
Defining Minimum Treatment Parameters of Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma: An Expert Consensus
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 성진실 | - |
dc.date.accessioned | 2024-05-23T03:27:16Z | - |
dc.date.available | 2024-05-23T03:27:16Z | - |
dc.date.issued | 2024-03 | - |
dc.identifier.issn | 1879-8500 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/199227 | - |
dc.description.abstract | Purpose: External beam radiation therapy (EBRT) is a highly effective treatment in select patients with hepatocellular carcinoma (HCC). However, the Barcelona Clinic Liver Cancer system does not recommend the use of EBRT in HCC due to a lack of sufficient evidence and intends to perform an individual patient level meta-analysis of ablative EBRT in this population. However, there are many types of EBRT described in the literature with no formal definition of what constitutes “ablative.” Thus, we convened a group of international experts to provide consensus on the parameters that define ablative EBRT in HCC. Methods and Materials: Fundamental parameters related to dose, fractionation, radiobiology, target identification, and delivery technique were identified by a steering committee to generate 7 Key Criteria (KC) that would define ablative EBRT for HCC. Using a modified Delphi (mDelphi) method, experts in the use of EBRT in the treatment of HCC were surveyed. Respondents were given 30 days to respond in round 1 of the mDelphi and 14 days to respond in round 2. A threshold of ≥70% was used to define consensus for answers to each KC. Results: Of 40 invitations extended, 35 (88%) returned responses. In the first round, 3 of 7 KC reached consensus. In the second round, 100% returned responses and consensus was reached in 3 of the remaining 4 KC. The distribution of answers for one KC, which queried the a/b ratio of HCC, was such that consensus was not achieved. Based on this analysis, ablative EBRT for HCC was defined as a BED10 ≥80 Gy with daily imaging and multiphasic contrast used for target delineation. Treatment breaks (eg, for adaptive EBRT) are allowed, but the total treatment time should be ≤6 weeks. Equivalent dose when treating with protons should use a conversion factor of 1.1, but there is no single conversion factor for carbon ions. Conclusions: Using a mDelphi method assessing expert opinion, we provide the first consensus definition of ablative EBRT for HCC. Empirical data are required to define the a/b of HCC. © 2023 | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | Elsevier | - |
dc.relation.isPartOf | PRACTICAL RADIATION ONCOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.subject.MESH | Ambulatory Care Facilities | - |
dc.subject.MESH | Carbon | - |
dc.subject.MESH | Carcinoma, Hepatocellular* / radiotherapy | - |
dc.subject.MESH | Consensus | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Liver Neoplasms* / radiotherapy | - |
dc.title | Defining Minimum Treatment Parameters of Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma: An Expert Consensus | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Radiation Oncology (방사선종양학교실) | - |
dc.contributor.googleauthor | Ted K Yanagihara | - |
dc.contributor.googleauthor | Joel E Tepper | - |
dc.contributor.googleauthor | Andrew M Moon | - |
dc.contributor.googleauthor | Aisling Barry | - |
dc.contributor.googleauthor | Meritxell Molla | - |
dc.contributor.googleauthor | Jinsil Seong | - |
dc.contributor.googleauthor | Ferran Torres | - |
dc.contributor.googleauthor | Smith Apisarnthanarax | - |
dc.contributor.googleauthor | Michael Buckstein | - |
dc.contributor.googleauthor | Higinia Cardenes | - |
dc.contributor.googleauthor | Daniel T Chang | - |
dc.contributor.googleauthor | Mary Feng | - |
dc.contributor.googleauthor | Chandan Guha | - |
dc.contributor.googleauthor | Christopher L Hallemeier | - |
dc.contributor.googleauthor | Maria A Hawkins | - |
dc.contributor.googleauthor | Morten Hoyer | - |
dc.contributor.googleauthor | Hiromitsu Iwata | - |
dc.contributor.googleauthor | Salma K Jabbour | - |
dc.contributor.googleauthor | Lisa Kachnic | - |
dc.contributor.googleauthor | Jordan Kharofa | - |
dc.contributor.googleauthor | Tae Hyun Kim | - |
dc.contributor.googleauthor | Alexander Kirichenko | - |
dc.contributor.googleauthor | Eugene J Koay | - |
dc.contributor.googleauthor | Hirokazu Makishima | - |
dc.contributor.googleauthor | Joel Mases | - |
dc.contributor.googleauthor | Jeffrey J Meyer | - |
dc.contributor.googleauthor | Pablo Munoz-Schuffenegger | - |
dc.contributor.googleauthor | Dawn Owen | - |
dc.contributor.googleauthor | Hee Chul Park | - |
dc.contributor.googleauthor | Jordi Saez | - |
dc.contributor.googleauthor | Nina N Sanford | - |
dc.contributor.googleauthor | Marta Scorsetti | - |
dc.contributor.googleauthor | Grace L Smith | - |
dc.contributor.googleauthor | Jennifer Y Wo | - |
dc.contributor.googleauthor | Sang Min Yoon | - |
dc.contributor.googleauthor | Theodore S Lawrence | - |
dc.contributor.googleauthor | Maria Reig | - |
dc.contributor.googleauthor | Laura A Dawson | - |
dc.identifier.doi | 10.1016/j.prro.2023.08.016 | - |
dc.contributor.localId | A01956 | - |
dc.relation.journalcode | J04363 | - |
dc.identifier.eissn | 1879-8519 | - |
dc.identifier.pmid | 38244026 | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S187985002300276X | - |
dc.contributor.alternativeName | Seong, Jin Sil | - |
dc.contributor.affiliatedAuthor | 성진실 | - |
dc.citation.volume | 14 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 134 | - |
dc.citation.endPage | 145 | - |
dc.identifier.bibliographicCitation | PRACTICAL RADIATION ONCOLOGY, Vol.14(2) : 134-145, 2024-03 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.